Ö

Özlem Göker-Alpan

Lysosomal and Rare Disorders Research and Treatment Center

ORCID: 0000-0003-4758-6793

262 papers and 6.3k citations.

PubIndex Score58Top 42% · seniorHow it's scored

262Publications

6.3kTotal Citations

First publication: 2002First senior author: 2010

Top publicationsby citations

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Raphael Schiffmann, Derralynn Hughes et al.|New England Journal of Medicine|2016

Cited by 555

Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1‐year Phase 1/2 clinical trial

Raphael Schiffmann, Derralynn Hughes, Özlem Göker-Alpan et al.|Journal of Inherited Metabolic Disease|2019

Cited by 137

The definition of neuronopathic Gaucher disease

Raphael Schiffmann, Ari Zimran, David Arkadir et al.|Journal of Inherited Metabolic Disease|2020

Cited by 102

Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases

Margarita M. Ivanova, Özlem Göker-Alpan|PLoS ONE|2019

Cited by 78

Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease

Margarita M. Ivanova, Özlem Göker-Alpan|PLoS ONE|2021

Cited by 17

Indexing the rest of 262 publications…